ASCENTAGE PHARMA GR-ADR (AAPG) Stock Price & Overview
NASDAQ:AAPG
The current stock price of AAPG is 24.22 USD. Today AAPG is down by -1.1%. In the past month the price decreased by -1.22%. In the past year, price increased by 27.47%.
AAPG Key Statistics
- Market Cap
- 2.252B
- P/E
- N/A
- Fwd P/E
- 19.07
- EPS (TTM)
- -1.90
- Dividend Yield
- N/A
AAPG Stock Performance
AAPG Stock Chart
AAPG Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AAPG. When comparing the yearly performance of all stocks, AAPG turns out to be only a medium performer in the overall market: it outperformed 51.18% of all stocks.
AAPG Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AAPG. AAPG may be in some trouble as it scores bad on both profitability and health.
AAPG Earnings
AAPG Forecast & Estimates
13 analysts have analysed AAPG and the average price target is 32.13 USD. This implies a price increase of 32.65% is expected in the next year compared to the current price of 24.22.
For the next year, analysts expect an EPS growth of -185.96% and a revenue growth -42.1% for AAPG
AAPG Groups
Sector & Classification
AAPG Financial Highlights
Over the last trailing twelve months AAPG reported a non-GAAP Earnings per Share(EPS) of -1.9. The EPS decreased by -184.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -38.05% | ||
| ROE | -174.06% | ||
| Debt/Equity | 1.99 |
AAPG Ownership
AAPG Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.34 | 402.577B | ||
| AMGN | AMGEN INC | 16.55 | 203.574B | ||
| GILD | GILEAD SCIENCES INC | 16.52 | 181.247B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.4 | 125.079B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.57 | 81.897B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.95 | 42.495B | ||
| INSM | INSMED INC | N/A | 30.048B | ||
| BIIB | BIOGEN INC | 11.85 | 27.955B | ||
| NTRA | NATERA INC | N/A | 27.865B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.24 | 23.875B | ||
| MRNA | MODERNA INC | N/A | 22.105B | ||
| EXAS | EXACT SCIENCES CORP | 340.18 | 19.738B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.736B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AAPG
Company Profile
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Company Info
IPO: 2019-10-28
ASCENTAGE PHARMA GR-ADR
68 Xinqing Road, Suzhou Industrial Park
Suzhou JIANGSU CN
Employees: 605
ASCENTAGE PHARMA GR-ADR / AAPG FAQ
What does AAPG do?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
What is the stock price of ASCENTAGE PHARMA GR-ADR today?
The current stock price of AAPG is 24.22 USD. The price decreased by -1.1% in the last trading session.
What is the dividend status of ASCENTAGE PHARMA GR-ADR?
AAPG does not pay a dividend.
How is the ChartMill rating for ASCENTAGE PHARMA GR-ADR?
AAPG has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for ASCENTAGE PHARMA GR-ADR?
ASCENTAGE PHARMA GR-ADR (AAPG) currently has 605 employees.
Can you provide the ownership details for AAPG stock?
You can find the ownership structure of ASCENTAGE PHARMA GR-ADR (AAPG) on the Ownership tab.
What is the outstanding short interest for ASCENTAGE PHARMA GR-ADR?
The outstanding short interest for ASCENTAGE PHARMA GR-ADR (AAPG) is 0% of its float.